Development of Albuminuria and Glomerular Lesions in Normoglycemic B6 Recipients of db/db Mice Bone Marrow
The Role of Mesangial Cell Progenitors
- Feng Zheng1,
- Flavia Cornacchia1,
- Ivonne Schulman1,
- Anita Banerjee1,
- Qing-li Cheng1,
- Mylene Potier1,
- Anna Rita Plati1,
- Mariana Berho1,
- Sharon J. Elliot1,
- Jie Li2,
- Alessia Fornoni1,
- Yun-Juan Zang1,
- Ariel Zisman1,
- Liliane J. Striker1 and
- Gary E. Striker1
- 1Department of Medicine, Vascular Biology Institute, University of Miami School of Medicine, Miami, Florida
- 2Department of Dermatology, Vascular Biology Institute, University of Miami School of Medicine, Miami, Florida
- Address correspondence and reprint requests to Feng Zheng, MD, University of Miami School of Medicine, Rosenstiel Medical Science Bldg., Rm. 1023A, 1600 NW 10th Ave., Miami, FL, 33136. E-mail: fzheng{at}med.miami.edu
Abstract
The pathologic hallmarks of diabetic nephropathy are excess mesangial extracellular matrix (ECM) and mesangial cell proliferation. We previously showed that mesangial cell phenotypic changes play an important role in the pathogenesis of diabetic nephropathy. We concluded that phenotypic changes were present in bone marrow (BM)-derived mesangial cell progenitors, as transplantation of BM from db/db mice, a model of type 2 diabetic nephropathy, transferred the db genotype and a nephropathy phenotype to naive B6 mice recipients. The recipients did not develop diabetes; however, they did develop albuminuria and glomerular lesions mirroring those in the donors (i.e., glomerular hypertrophy, increased ECM, and increased cell number with cell proliferation). We found that matrix metalloproteinase 2 (MMP-2) facilitated invasion of the mesangial cells into ECM and proliferation in vitro. Thus, increased MMP-2 activity in db/db mesangial cell progenitors may partially explain increased mesangial cell repopulation and proliferation in B6 recipients of db/db BM. In summary, BM-derived mesangial cell progenitors may play a crucial role in the development and progression of ECM accumulation and mesangial cell proliferation in this model of diabetic nephropathy in type 2 diabetes.
- APMA, p-aminophenylmercuric acetate
- BM, bone marrow
- BrdU, bromodeoxyuridine
- DMEM, Dulbecco’s modified Eagle’s medium
- ECM, extracellular matrix
- FBS, fetal bovine serum
- GFP, green fluorescence protein
- GTT, glucose tolerance test
- ITT, insulin tolerance test
- MMP-2, matrix metalloproteinase 2
- OA-Hy, cis-octadecenoyl-N-hydroxylamide oleoyl-N-hydroxylamide
- PAS, periodic acid Schiff
- UAE, urinary albumin excretion
Footnotes
-
- Accepted May 28, 2004.
- Received March 4, 2004.
- DIABETES














